| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | -0.0056 | 0.9 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.0045 | 0.9 |
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | 0.0037 | 0.9 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | -0.0031 | 0.9 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | -0.0025 | 0.9 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.0032 | 0.9 |
| mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0028 | 0.9 |
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | 0.0043 | 0.9 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | 0.0052 | 0.9 |